The Age-related Macular Degeneration market across the seven major markets continues to show strong growth potential, driven by rising prevalence and innovation in treatment options.

🔹 In 2021, the total AMD market size was valued at approximately USD 9,840 million, and it is expected to grow substantially by 2034.
🔹 Market segmentation highlights:

Dry AMD market: ~USD 1,377 million

Wet AMD market: ~USD 8,463 million, accounting for the largest share

🚀 Market growth is expected to accelerate due to:

Increasing diagnosed prevalent population

Anticipated launch of potential therapies

Strong focus on Wet AMD innovation

💊 Emerging therapies such as OPT-302, KSI-301, RGX-314, AKST4290, and others are poised to bring a significant positive shift, particularly in the Wet AMD market.

🔍 Discover detailed market insights, forecasts, and competitive dynamics in the full report:
👉 https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market?utm_source=sm&utm_medium=promotion&utm_campaign=mpr

#AMDMarket #WetAMD #DryAMD